GPT-Rosalind Launched for Drug Discovery and Life Sciences Research

OpenAI launched GPT-Rosalind, a specialized large language model designed for life sciences and biological research applications. The model expands OpenAI's enterprise vertical strategy as the company reports $2 billion in monthly revenue and prepares for a major IPO while pursuing aggressive advertising revenue targets.